DeTEKting Ubiquitination of APC/C Substrates  by Haas, Arthur L. & Wilkinson, Keith D.
RefeRences
Benit, P., Slama, A., Cartault, F., Giurgea, I., Chre-
tien, D., Lebon, S., Marsac, C., Munnich, A., Rotig, 
A., and Rustin, P. (2004). J. Med. Genet. 41, 14–17.
Cullen, S.P., and Martin, S.J. (2008). Cell Death 
Differ. 15, 251–262.
Hirst, J., Carroll, J., Fearnley, I.M., Shannon, R.J., 
and Walker, J.E. (2003). Biochim. Biophys. Acta 
1604, 135–150.
Huang, G., Chen, Y., Lu, H., and Cao, X. (2007). 
Cell Death Differ. 14, 327–337.
Kang, B.H., Plescia, J., Dohi, T., Rosa, J., Doxsey, 
S.J., and Altieri, D.C. (2007). Cell 131, 257–270.
Kutik, S., Guiard, B., Meyer, H.E., Wiedemann, N., 
and Pfanner, N. (2007). J. Cell Biol. 179, 585–591.
Ladha, J.S., Tripathy, M.K., and Mitra, D. (2005). 
Cell Death Differ. 12, 1417–1428.
Martinvalet, D., Zhu, P., and Lieberman, J. (2005). 
Immunity 22, 355–370.
Martinvalet, D., Dykxhoorn, D.M., Ferrini, R., and 
Lieberman, J. (2008). Cell, this issue.
Reeves, M.B., Davies, A.A., McSharry, B.P., Wilkin-
son, G.W., and Sinclair, J.H. (2007). Science 316, 
1345–1348.
Ricci, J.E., Munoz-Pinedo, C., Fitzgerald, P., Bail-
ly-Maitre, B., Perkins, G.A., Yadava, N., Scheffler, 
I.E., Ellisman, M.H., and Green, D.R. (2004). Cell 
117, 773–786.DeTeKting Ubiquitination of APc/c 
substrates
Arthur L. Haas1 and Keith D. Wilkinson2,*
1Department of Biochemistry and Molecular Biology, Louisiana State University School of Medicine, New Orleans, LA 70112, USA
2Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA
*Correspondance: genekdw@emory.edu
DOI 10.1016/j.cell.2008.04.034
Regulated protein degradation by the ubiquitin-proteasome pathway ensures the unidirectionality of 
mitotic progression by removing cell-cycle regulators required at earlier stages. The APC/C ubiquitin-
protein ligase targets proteins by appending polyubiquitin degradation signals that are subsequently 
recognized by the 26S proteasome. Reporting in this issue, Jin et al. (2008) identify a TEK motif in 
both ubiquitin and substrates of APC/C that mediates assembly of these degradation signals.Cell-cycle progression relies on precise 
transitions through an ordered sequence 
of events coordinated in space and time. 
The intricate molecular dance of genome 
replication, spindle assembly, sister 
chromatid segregation, and cytokine-
sis is directed by the regulated action 
of cyclin-dependent protein kinases 
(Cdks). In eukaryotes, the forward pro-
gression of the cell cycle is propelled by 
the regulated degradation of cyclins and 
other proteins required at earlier steps in 
the cell cycle. Ubiquitin carrier proteins 
(E2-conjugating enzymes or Ubcs) act 
in concert with the anaphase-promot-
ing complex/cyclosome (APC/C) and 
the Cdc20 targeting adaptor protein to 
assemble polyubiquitin degradation sig-
nals on cyclins, thus signaling destruc-
tion of these regulatory oscillators by the 
26S proteasome. The APC/C similarly 
engages the Cdh1 targeting adaptor pro-
tein to initiate anaphase by licensing the 
degradation of securin, an inhibitor of the 570 Cell 133, May 16, 2008 ©2008 Elsevier Iubiquitin-independent protease known 
as separase that initiates sister chro-
matid segregation by degrading their 
cohesin protein linker. Thus, regulated 
protein degradation by the ubiquitin/26S 
proteasome pathway serves as a com-
mon thread that links the coordinated 
action of the cyclins with other cell-cycle 
regulators (reviewed in Peters, 2006). 
Work by Jin et al. (2008) reported in this 
issue now reveals the mechanism by 
which APC/C directs assembly of polyu-
biquitin degradation signals.
Polyubiquitin chains can be formed by 
the conjugation of ubiquitin molecules to 
one another via any of the seven lysine 
residues that ubiquitin contains. How-
ever, because only a subset of these 
polyubiquitin chains can target proteins 
to the proteasome, productive ubiq-
uitination by the APC/C must exhibit 
specificity in the type of ubiquitin-chain 
linkage formed upon polyubiquitina-
tion. Previous work has demonstrated nc.by quantitative mass spectrometry that 
the APC/CCdc20 complex of the frog Xeno-
pus enlists the E2 UbcH10 to assemble 
degradation-competent polyubiquitin 
chains in vitro on cyclin B1 (Kirkpatrick 
et al., 2006). These polyubiquitin chains 
not only contain the canonical degrada-
tion-signaling chain linkage of lysine 48 
(K48) (25%) but also chain linkages of 
lysine 11 (K11) (60%) and lysine 63 (K63) 
(15%). To further examine chain selec-
tivity, Jin et al. (2008) evaluated APC/C 
ubiquitination in human cell extracts har-
boring mutant ubiquitin in which only a 
single lysine or all but one lysine were 
changed to arginine, a residue to which 
ubiquitin cannot be conjugated. Using 
cyclin B1 or securin ubiquitination and 
degradation as the functional readout 
of ubiquitin chain formation, the authors 
demonstrated that human APC/CCdc20 
and APC/CCdh1 form predominantly (but 
not exclusively) K11-linked chains. Sur-
prisingly, these chains are competent 
figure 1. TeK-Box-Mediated Ubiquitin chain formation
A motif termed the TEK-box (for its conserved threonine, glutamate, and lysine residues) directs site-specific ubiquitination of APC/C substrates and elongation 
of lysine 11 (K11)-linked ubiquitin chains. The substrate TEK-box is necessary for nucleation and a D-box on the substrate is necessary for processive ubiquit-
ination. The TEK-box on ubiquitin is used to recognize the distal ubiquitin of a polyubiquitin chain and orient K11 to attack the incoming ubiquitin.to signal efficient degradation by the 
proteasome. Consistent with other data 
obtained using Ubc4 (Kirkpatrick et al., 
2006), Jin and colleagues observed that 
substitution of the closely related E2 
paralog UbcH5 results in more abundant 
chain linkages to K48 and K63. However, 
Jin et al. (2008) observed less efficient 
proteolytic targeting with the E2 substi-
tution and interpreted these results as 
evidence that UbcH5 does not function 
with APC/C in vivo.
The mechanisms of polyubiquitin 
chain formation by ubiquitin ligases has 
been hotly debated. Early assumptions 
held that ligases first append a single 
ubiquitin to the target protein (termed 
nucleation by Jin et al.) before catalyz-
ing further elongation of the chain. Other 
models suggest that the ubiquitin chain 
is assembled first and then attached to 
the target protein. Currently, we can only 
say for certain that ubiquitin ligases have 
evolved different strategies for catalyz-
ing chain formation. Within the ubiquitin 
fusion degradation (UFD) pathway, chain 
nucleation and elongation are catalyzed 
by different ligases (Koegl et al., 1999). 
For example, the E2 Ubc3/Cdc34 cata-
lyzes both chain nucleation and elonga-
tion to form K48-linked chains on SCF-like 
ubiquitin ligases (Petroski and Deshaies, 
2005). Occasionally, orthologous ligases 
from different species exhibit distinct 
E2 preferences: budding yeast APC/C 
requires Ubc4 (closely related to UbcH5) 
for the chain nucleation step and Ubc1 
for K48-linked chain elongation, whereas 
higher eukaryotes use UbcH10 for both steps (Rodrigo-Brenni and Morgan, 2007; 
Jin et al., 2008). Interestingly, UbcH10 
is found only among higher eukaryotes 
and its autocatalytic ubiquitination by 
the APC/C results in degradation of the 
E2-conjugating enzyme at the appro-
priate point in the cell cycle (Rape and 
Kirschner, 2004). Most recently, in direct 
contradiction to the canonical model 
of sequential ubiquitin addition, some 
ligases have been shown to assemble 
polyubiquitin chains on their cognate E2 
enzymes prior to transferring the entire 
chain to the target (Li et al., 2007; Ravid 
and Hochstrasser, 2007).
Regardless of the exact details of 
chain assembly, all ligases must posi-
tion the acceptor lysine of the target 
protein (or previous ubiquitin) to allow 
the approach of the activated thiolester 
of the E2-bound ubiquitin for productive 
nucleophilic attack in the chain conjuga-
tion process. The mechanisms by which 
this specificity in ubiquitin orientation 
is achieved are largely undefined. By 
mutating surface amino acids on ubiq-
uitin, Jin et al. identified five residues 
that blocked UbcH10-dependent APC/
C-catalyzed chain formation and that 
stabilized securin against destruction 
(Jin et al., 2008). Three of these residues 
were adjacent to K11 and formed a motif 
termed the TEK-box for its conserved 
threonine, glutamate, and lysine resi-
dues. The authors surveyed APC/C sub-
strates and identified short TEK-box-like 
motifs that were required for UbcH10- 
but not UbcH5-dependent conjugation 
by APC/C. Furthermore, mutation of Cell these motifs blocked degradation by the 
26S proteasome. The authors suggest 
that the TEK-box represents a new inter-
action motif that directs a catalytically 
competent orientation of the UbcH10-
ubiquitin thiolester with the acceptor 
lysine residue when present on either 
a ubiquitin moiety during chain elonga-
tion or on the target protein during the 
nucleation step (Figure 1). This is a new 
consensus ubiquitination sequence and 
is reminiscent of a similar motif critical 
for lysine deprotonation during conjuga-
tion of the ubiquitin-like protein Sumo 
by the E2 Ubc9 (Yunus and Lima, 2006). 
These seminal insights suggest a gen-
eral mechanism for nucleation and elon-
gation that holds for both the canonical 
(chain elongation by sequential addition) 
and alternate model (concerted chain 
formation prior to addition to the target) 
of ubiquitination.
Recent work focused on polyubiquitin 
chain formation has provided a broad 
outline for the different strategies used 
by ubiquitin ligases in assembling these 
degradation signals. Future work directed 
at a more detailed kinetic and mechanis-
tic understanding of the individual steps 
involved in ubiquitin chain formation 
will shed new light on how specificity in 
ubiquitin signaling is achieved. In addi-
tion, determining the intrinsic affinities 
of the E2-ubiquitin thiolesters (in order 
to distinguish cognate from noncognate 
Ubc paralogs) and the structures for the 
individual steps within the catalytic cycle 
should help to clarify many of the out-
standing questions in this exciting field.133, May 16, 2008 ©2008 Elsevier Inc. 571
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One of the major conundrums in neuro-
logical disease research is why mutations 
in genes that are widely expressed both 
inside and outside of the nervous system 
can lead to diseases characterized by 
degeneration of highly specific subpopu-
lations of neurons. In the case of many 
dominant diseases, such as spinocer-
ebellar ataxia and familial amyotrophic 
lateral sclerosis, it appears that neurons 
are selectively vulnerable to acquired 
protein toxicity conferred by specific 
amino acid changes. In contrast, reces-
sive diseases generally result from inac-
tivation or loss of function of a protein. In 
the neurological disease spinal muscular 
atrophy (SMA), the SMN (survival of motor 
neurons) gene is inactivated. The normal 
SMN protein is widely expressed in all tis-
sues and is considered to be part of the 
so-called “housekeeping” system of the 
cell. It has been widely assumed that such 
housekeeping functions are part of basal 
cellular activity and therefore are unlikely 
to be regulated in a tissue-specific and 
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time-dependent manner. In this issue of 
Cell, Zhang et al. (2008) provide some 
surprising new insights into the function 
of the SMN protein, which suggest that 
the general regulation of splicing through 
assembly of snRNPs may be more tis-
sue specific than previously appreciated. 
SMA is characterized by highly selective 
degeneration of motor neurons, leading 
to weakness and wasting of muscle and 
can be fatal. The restriction of pathology 
to one specialized kind of neuron is par-
ticularly surprising given the fact that SMN 
is expressed in every cell in the body and 
its complete absence is uniformly associ-
ated with cell death (Schrank et al., 1997). 
SMA is caused by mutations at the SMN 
locus, which result in the deletion of the 
SMN1 gene and variable residual copies 
of SMN2, a paralog that arose through an 
evolutionary duplication event. Due to a 
silent nucleotide change in exon 7 that 
abolishes an exonic splicing enhancer, 
SMN2 produces approximately 10% of 
the full-length functional SMN protein 
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Mol. Biol. 13, 491–499.compared with SMN1. SMA occurs at a 
critical threshold level of SMN when this 
protein is reduced by approximately 80%. 
This marked decrease in SMN affects 
motor neurons but is sufficient to ensure 
the normal function of all other cells (Lefe-
bvre et al., 1997).
SMN and its associated protein com-
plex is now known to have a central role 
in the integration of Sm core protein hep-
tamers with snRNAs into snRNP com-
plexes prior to importation of these com-
plexes into the nucleus to participate in 
the spliceosome (Kolb et al., 2007). Thus, 
reduction in SMN levels should lead to 
a generalized defect in splicing across a 
range of RNA transcripts. Could a defect 
in this basic function common to all cells 
really result in a phenotype that is spe-
cific to motor neurons?
Intriguingly, the SMN protein is also 
present in the axonal compartment of 
motor neurons and other nerve cells and 
is localized in granules that are actively 
transported into neuronal processes and 
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